{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:02:51Z","timestamp":1791903771146,"version":"4.3.4"},"reference-count":10,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2011,5,3]],"date-time":"2011-05-03T00:00:00Z","timestamp":1304380800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Obstet and Gynaecol"],"published-print":{"date-parts":[[2011,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Aim:\u2002<\/jats:bold> Our objective was to study the prevalence and risk of metabolic syndrome (MS) among adolescent Indian girls with polycystic ovary syndrome (PCOS), compared to those without, as per the recent \u2018joint interim statement\u2019 criteria. We also aimed to compare the selected study parameters across PCOS adolescents with and without MS.<\/jats:p><jats:p><jats:bold>Material &amp; Methods:\u2002<\/jats:bold> Cross\u2010sectional data of 96 adolescent girls were retrospectively analyzed applying the 2009 \u2018joint interim criteria\u2019 for MS. Fifty\u2010one of them were diagnosed with PCOS as per the Androgen excess society criteria 2006. The remaining 45 adolescent girls (no androgen excess manifestations and regular cycles) formed the comparison group.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> The prevalence of MS among adolescents with PCOS (60.78%; 95% CI\u2003=\u200350.78%, 70.78%) was significantly more compared to those without (<jats:italic>P<\/jats:italic>\u2003=\u20030.002). The odds ratio of MS among PCOS adolescents was 4.26 (95% CI\u2003=\u20031.79, 10.15). Only the mean waist circumference differed significantly between the PCOS and non\u2010PCOS groups (<jats:italic>P<\/jats:italic>\u2003=\u20030.046). Interestingly, the contrast between the MS and non\u2010MS subgroups of the PCOS adolescent sample produced significant differences in body mass index, waist circumference, blood pressure and biochemical parameters such as fasting plasma glucose, high\u2010density lipoprotein\u2010cholesterol and triglyceride levels.<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold> Adolescent Indian girls with PCOS were reported to have 4.26 times more chances of developing MS compared to those without. Waist circumference was found to be the cheapest and simplest significant marker of MS. The study underlines the need for routine screening of MS among adolescent girls suffering from PCOS to reduce future co\u2010morbidities.<\/jats:p>","DOI":"10.1111\/j.1447-0756.2010.01516.x","type":"journal-article","created":{"date-parts":[[2011,5,3]],"date-time":"2011-05-03T06:17:36Z","timestamp":1304403456000},"page":"1303-1307","source":"Crossref","is-referenced-by-count":20,"title":["Prevalence and risk of metabolic syndrome in adolescent Indian girls with polycystic ovary syndrome using the 2009 \u2018joint interim criteria\u2019"],"prefix":"10.1111","volume":"37","author":[{"given":"Sudhindra M.","family":"Bhattacharya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayan","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,5,3]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.192644"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1198"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0178"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0828-282X(10)70360-3"},{"key":"e_1_2_5_6_2","first-page":"2492","article-title":"Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance","volume":"91","author":"Coviella AD","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.5.1380"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02434.x"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2006.12.003"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-1707"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ics.2003.12.089"}],"container-title":["Journal of Obstetrics and Gynaecology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1447-0756.2010.01516.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1447-0756.2010.01516.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T03:01:56Z","timestamp":1697338916000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/j.1447-0756.2010.01516.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,3]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["10.1111\/j.1447-0756.2010.01516.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1447-0756.2010.01516.x","archive":["Portico"],"relation":{},"ISSN":["1341-8076","1447-0756"],"issn-type":[{"value":"1341-8076","type":"print"},{"value":"1447-0756","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,3]]}}}